1. Home
  2. ZKIN vs TNXP Comparison

ZKIN vs TNXP Comparison

Compare ZKIN & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZKIN
  • TNXP
  • Stock Information
  • Founded
  • ZKIN 2015
  • TNXP 2007
  • Country
  • ZKIN China
  • TNXP United States
  • Employees
  • ZKIN N/A
  • TNXP N/A
  • Industry
  • ZKIN Metal Fabrications
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZKIN Industrials
  • TNXP Health Care
  • Exchange
  • ZKIN Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • ZKIN 19.8M
  • TNXP 19.5M
  • IPO Year
  • ZKIN 2017
  • TNXP N/A
  • Fundamental
  • Price
  • ZKIN $0.52
  • TNXP $0.20
  • Analyst Decision
  • ZKIN
  • TNXP Strong Buy
  • Analyst Count
  • ZKIN 0
  • TNXP 2
  • Target Price
  • ZKIN N/A
  • TNXP $53.50
  • AVG Volume (30 Days)
  • ZKIN 94.3K
  • TNXP 51.5M
  • Earning Date
  • ZKIN 09-30-2024
  • TNXP 11-12-2024
  • Dividend Yield
  • ZKIN N/A
  • TNXP N/A
  • EPS Growth
  • ZKIN N/A
  • TNXP N/A
  • EPS
  • ZKIN N/A
  • TNXP N/A
  • Revenue
  • ZKIN $114,831,443.00
  • TNXP $11,291,000.00
  • Revenue This Year
  • ZKIN N/A
  • TNXP $62.53
  • Revenue Next Year
  • ZKIN N/A
  • TNXP $26.17
  • P/E Ratio
  • ZKIN N/A
  • TNXP N/A
  • Revenue Growth
  • ZKIN 5.20
  • TNXP 183.05
  • 52 Week Low
  • ZKIN $0.38
  • TNXP $0.12
  • 52 Week High
  • ZKIN $1.35
  • TNXP $22.08
  • Technical
  • Relative Strength Index (RSI)
  • ZKIN 46.96
  • TNXP 69.43
  • Support Level
  • ZKIN $0.49
  • TNXP $0.13
  • Resistance Level
  • ZKIN $0.58
  • TNXP $0.28
  • Average True Range (ATR)
  • ZKIN 0.06
  • TNXP 0.02
  • MACD
  • ZKIN -0.00
  • TNXP 0.01
  • Stochastic Oscillator
  • ZKIN 34.52
  • TNXP 49.47

About ZKIN ZK International Group Co. Ltd

ZK International Group Co Ltd is engaged in the manufacture and marketing of metal pipes. The company is specialized in producing double-press thin-walled stainless steel tubes and fittings, carbon steel tubes and fittings, single-press tubes and fittings, and stainless-steel strips. The products are used in restaurants, hotels, hospitals, firefighting, food, beverage, ships, engines, industrial seawater desalination and systems of direct-drinking water, cold /hot water supply, city water supply, and gas of large/middle scale construction projects.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: